Pasar al contenido principal

I+D DE SISTEMAS ESPECIALIZADOS DE LIBERACION DE FARMACOS PARA EL TRATAMIENTO DE PATOLOGIAS INFLAMATORIAS Y DEGENERATIVAS OCULARES

PID2022-142350OB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Long acting injectables & implants: advances in intraocular drug delivery

  • Cuello Rodríguez, Selene
  • Blanco Fernández, Guillermo
  • García Otero, Xurxo
  • Díaz Tomé, Victoria
  • Otero Espinar, Francisco Javier
  • Seoane Viaño, Iria
The treatment of posterior segment ocular diseases, such as age-related macular degeneration and diabetic retinopathy, poses a significant challenge for ophthalmologists due to the eye’s complex anatomy and physiological barriers. To overcome these challenges, intravitreal drug delivery offers a promising solution by enabling direct administration of therapeutic agents into the pathological area through an injection. However, these injections are highly invasive and carry several risks, including infection, retinal detachment, and increased intraocular pressure. As a result, considerable efforts have been directed toward developing drug delivery platforms (implants, nano- and microparticles, and hydrogels) capable of providing sustained drug release over extended periods. These long-acting systems aim to reduce the frequency of injections, thereby improving patient quality of life and decreasing the overall economic burden of treatment. This review provides an overview of intravitreal drug delivery systems, evaluating their clinical applicability and the potential challenges that must be addressed before they can be successfully translated into marketed drug products.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Intravitreal Administration of Adalimumab-Loaded Poly(Lactic-co-Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics

  • García Otero, Xurxo
  • Varela Fernández, Rubén
  • Cuartero Martínez, Andrea
  • Gómez Lado, Noemí
  • González Barcia, Miguel
  • Mondelo García, Cristina
  • Feitosa, Carolina
  • Aguiar Fernández, Pablo
  • Fernández Ferreiro, Anxo
  • Otero Espinar, Francisco Javier
Adalimumab, a monoclonal antibody used for treating inflammatory diseases, including eye diseases, faces challenges in biodistribution and targeted delivery. Nanoparticle (NP)-based drug delivery systems have shown promise in enhancing the pharmacokinetic profiles of biologic drugs. This study aims to develop, and characterize intravitreal adalimumab-loaded poly(lactic-co-glycolic acid) (PLGA) NPs to improve antibody distribution and therapeutic efficacy. Characterization studies, morphological examination, and quantitative, stability, and physical properties are conducted. In vitro release kinetics are assessed using a dialysis membrane method. In vivo biodistribution is studied in rats after intravitreal administration by Positron Emission Tomography/Computed Tomography imaging. The optimized NPs were spherical (around 300 nm) with a surface charge of about −20 mV. Encapsulation efficiency and drug loading reach values close to 100%. Stability studies showed minimal changes in particle size and drug content. In vitro release showed a biphasic pattern with an initial burst release followed by sustained release. Safety studies indicated no significant cytotoxicity or adverse effects. The adalimumab-loaded PLGA NPs demonstrate favorable physicochemical characteristics, stability, and release profiles. In vivo distribution revealed a change in the antibody's distribution pattern after intravitreal administration via NPs encapsulation. These findings suggest the potential for enhanced therapeutic outcomes and warrant further investigation in disease-specific models to explore the clinical potential of this NP-based delivery system.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Development of inert coatings to prevent drug retention in 3D-printed diffusion cells

  • Bendicho Lavilla, Carlos
  • Díaz Tomé, Victoria
  • Seoane Viaño, Iria
  • Luzardo Álvarez, Asteria María
  • Otero Espinar, Francisco Javier
Diffusion cells play a crucial role in the pharmaceutical and cosmetic fields by assessing the release and permeation of active pharmaceutical ingredients across membranes. However, commercially available glass-based devices, such as Franz diffusion cells, are expensive and fragile. The emergence of three-dimensional (3D) printing technology enables the creation of diffusion cells with cost-effective polymeric materials and resins, offering exceptional precision and custom geometries. Nonetheless, there are challenges associated with interactions between 3D printing materials and drug molecules. This work aimed to develop inert coatings for 3D-printed diffusion models. Diffusion devices were designed and 3D-printed with a stereolithography (SLA) 3D printer, and different coatings were applied. Then, two model drugs were used to evaluate drug retention by coated devices. Among the tested coatings, one of them showed great potential in preventing drug retention and was selected for subsequent experiments with different drugs and conditions. Finally, voriconazole eyedrops were used to confirm the viability of 3D-printed Franz diffusion cells as a drug release diffusion model. The favourable results obtained with the coating promote the use of 3D printing as a cost-effective manufacturing technology, capable of producing diffusion cells tailored to specific study requirements
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

  • Cuartero Martínez, Andrea
  • García Otero, Xurxo
  • Codesido, Jessica
  • Gómez Lado, Noemí
  • Mateos, Jesús
  • Bravo López, Susana Belén
  • Rodríguez-Fernández, Carmen Antía
  • González Barcia, Miguel
  • Aguiar Fernández, Pablo
  • Ortega-Hortas, Marcos
  • Otero Espinar, Francisco Javier
  • Fernández Ferreiro, Anxo
Uveitis is a group of inflammatory ocular pathologies. Endotoxin-Induced Uveitis (EIU) model represent a well-known model induced by administration of Lipopolysaccharide (LPS). The aim is to characterize two models of EIU through two routes of administration with novel noninvasive imaging techniques. 29 rats underwent Intraocular Pressure (IOP) measurements, Optical Coherence Tomography (OCT), proteomic analysis, and Positron Emission Tomography and Computed Tomography (PET/CT). Groups included healthy controls (C), BSS administered controls (Ci), systemically induced EIU with LPS (LPSs), and intravitreally induced EIU with LPS (LPSi) for IOP, OCT, and proteomic studies. For 18F-FDG PET/CT study, animals were divided into FDG-C, FDG-LPSs and FDG-LPSi groups and scanned using a preclinical PET/CT system. LPSi animals exhibited higher IOP post-induction compared to C and LPSs groups. LPSi showed increased cellular infiltrate, fibrotic membranes, and iris inflammation. Proinflammatory proteins were more expressed in EIU models, especially LPSi. PET/CT indicated higher eye uptake in induced models compared to FDG-C. FDG-LPSi showed higher eye uptake than FDG-LPSs but systemic uptake was higher in FDG-LPSs due to generalized inflammation. OCT is valuable for anterior segment assessment in experimental models. 18F-FDG PET/CT shows promise as a noninvasive biomarker for ocular inflammatory diseases. Intravitreal induction leads to higher ocular inflammation. These findings offer insights for future inflammatory disease research and drug studies.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Physicochemical and safety evaluation of an antioxidant ophthalmic hydrogel for corneal injuries

  • Cuello Rodríguez, Selene
  • Díaz Tomé, Victoria
  • Monte Vidal, Vinicius de
  • Martín Pastor, Manuel
  • Sarmento, Bruno
  • Otero Espinar, Francisco Javier
Corneal injuries are frequently associated with oxidative stress and standard treatment are only to prevent infection, reduce pain and inflammation. This work describes the development of antioxidant ophthalmic hydrogels containing Idebenone (IDB) and hydroxocobalamin (HCB) as a complement treatment for corneal injuries, using hydroxypropyl- β-cyclodextrin (HPβCD) to improve IDB aqueous solubility. Three hydrogels were prepared (hyaluronic acid, FAH; poloxamer 407, FP; and polyvinyl alcohol, FPVA) and characterized for physicochemical properties, mucoadhesion and safety. Phase-solubility assays supported 1:1 inclusion complex formation and achieved to solubilize a high IDB load. FP displayed thermogelling properties rheologically, showing increased viscosity between room and physiological temperatures. In vitro release in Franz cells indicated sustained delivery for both actives, best described by the Korsmeyer-Peppas model. Ex vivo bovine corneal permeation showed no detectable transcorneal diffusion of drugs, consistent with a local action on superficial corneal layers. FP exhibited suitable wettability on corneal surface and was selected for further evaluation. Antioxidant capacity assessed by FRAP demonstrated high activity for FP compared with conventional artificial tears based on HPMC or Hypromellose. Ocular safety was supported by BCOP and HET-CAM assays, showing no relevant impairment of corneal integrity or irritation, and cytotoxicity assays in human corneal epithelial cells and keratocytes showed the safety of the treatment. Additionally, C. Elegans survival assay confirmed the treatment́s safety. Overall, the developed hydrogel, composed of P407 and HPβCD, shows potential as a safe topical platform to increase ocular residence time and provide localized antioxidant support during corneal injuries management
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Design and evaluation of semi-solid lipid implants for controlled intravitreal release of bevacizumab

  • Blanco Fernández, Guillermo
  • Blanco Fernández, Bárbara
  • Fraga López, Francisco
  • Luzardo Álvarez, Asteria María
  • Fernández Ferreiro, Anxo
  • Otero Espinar, Francisco Javier
Bevacizumab is a monoclonal antibody used intravitreally as an anti-VEGF therapy for some ocular diseases. However, this type of treatment presents some limitations, such as the invasiveness of its administration and the need for frequent injections due to the clearance of the antibody from the vitreous chamber. Semi-solid lipid implants emerge as an attractive possibility for the sustained release of biological drugs like bevacizumab, so they could have great potential for the subsequent treatment of VEGF-dependent degenerative retinal pathologies, such as proliferative diabetic retinopathy or neovascular age-related macular degeneration. In this work, injectable lipid implants were designed based on the lipids Precirol® ATO 5, Tefose® 63, GeleolTM, and Tefose® 1500. The implants were easy to manufacture by melting and mixing. The surface of the implants was characterized by scanning electron microscopy, while the distribution of bevacizumab inside was characterized by confocal Raman mapping microscopy. Subsequently, the state of the antibody after release was evaluated by Raman Spectroscopy and Attenuated Total Reflection Infrared spectroscopy, showing an unaltered quaternary structure. Furthermore, the implants were able to sustain the antibody release for almost 40 days. Biocompatibility was assessed by assay with ARPE-19 cells. Finally, the calorimetry assay allowed us to refine the best possible formulation for further studies. This type of implant showed suitable properties as a potential therapeutic platform for the treatment of neovascular age-related macular degeneration and proliferative diabetic retinopathy, being injectable, easy to make, homogeneous, having sustained release and being biocompatible.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

On qualitative properties of replication and transfer of conjugative plasmids encoding antibiotic resistance genes

  • Ibarguen Mondragón, Eduardo
  • Esteva, Lourdes
  • Otero Espinar, María Victoria
  • Vega, Edgar
  • Cerón-Gómez, Miller
In order to advance in the fight against plasmid-mediated resistance, it is necessary to deepen our understanding of the role played by these DNA molecules. In this sense, the achievements obtained from experimentation validated by mathematical models have contributed to the discovery of key properties in the dynamics of antibiotic resistance. In this work, we attempt to characterize some of these properties through nonlinear functional responses of both plasmid replication and plasmid transfer. The results of the mathematical modeling performed here suggest that the emergence of antibiotic resistance in an individual due to the transfer of plasmid-borne resistance genes is directly associated with the production capacity of both recipient and donor bacteria. Whereas for persistence, in addition to bacterial replication, specific properties associated with plasmid replication and transfer are required.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Selective Laser Sintering 3D Printing of Drug-Loaded Intravitreal Implants

  • Seoane Viaño, Iria
  • Bendicho Lavilla, Carlos
  • Alfassam, Haya
  • Blanco Fernández, Bárbara
  • Basit, Abdul Waseh
  • Otero Espinar, Francisco Javier
Frequent intravitreal injections are the standard treatment for chronicretinal diseases, but they are costly and inconvenient and carry potentialcomplications. Intravitreal implants have emerged as an alternative approachcapable of delivering sustained drug levels over extended periods. However,current implant manufacturing techniques, predominantly extrusion-based,present limitations when processing labile drugs. In this study, biodegradableimplants are introduced, fabricated via selective laser sintering (SLS)3D printing to achieve extended, controlled release of dexamethasone andriboflavin. By adjusting laser scanning speeds, diverse release profiles over7 months are generated, after which the implant matrix fully degrades in therelease medium. SEM-EDX and Raman spectroscopy confirmed uniform drugdistribution in the implant, while XRPD, FTIR, and DSC analyses indicated thatthe drugs remained stable postmanufacturing. Additionally, investigationswith ARPE-19 retinal cell cultures demonstrated excellent cytocompatibilityof the implant. Overall, the findings confirm that SLS 3D printing isa promising approach for manufacturing intravitreal implants. This techniquenot only offers compatibility with a wide range of pharmaceutical compoundsbut also enables the tailoring of drug release by controlling the porosityof the implant. Consequently, SLS-based implants may improve patientoutcomes by reducing injection frequency and associated complications.